Keeping Up With Biosimilars

Biosimilar Regulatory and Practical Considerations When Selecting Biosimilar Use in the Marketplace

(B1) Biosimilar Regulatory and Practical Considerations When Selecting Biosimilar Use in the Marketplace

Wednesday, March 22, 2023

8:45 AM – 10:00 AM

Location: B1

ACPE UAN:0233-0000-23-021-L99-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

Adam Colborn, JD

Director, Government Relations
AMCP
Alexandria, VA
Gary Rice, RPh MS MBA CSP (he/him/his)

Senior Advisor
MedImpact Healthcare System, Inc
Fenton, MI

Moderator(s)

AD

Ajay Dalal, PharmD, MBA

Director of Clinical Services
Honest Rx Consulting
Southlake, Texas

This session will provide an understanding of the regulatory and practical considerations involved in the development and use of biosimilars. The audience will be equipped with insights from professionals to navigate the rapidly evolving biosimilar landscape. Faculty will examine potential barriers that interchangeability has towards the development of biosimilars on the market. This session will also encourage critical thinking and informed decision-making related to the use of biosimilars in patient care.

Learning Objectives::

At the completion of this activity, participants should be able to:

Describe the regulatory landscape of biosimilars in the U.S. including differences within each state.
Identify key factors relevant to the interchangeability of biosimilars and indications for use.
Discuss barriers that interchangeability potentially has towards biosimilars on the market.
Identify key characteristics of which biosimilars create different market dynamics in the US.